文献速递肝胆胰外科围术期管理与 ERAS

胰十二指肠切除术联合胰管纵行剖开吻合术治疗慢性胰腺炎:11例初步经验

[Pancreaticoduodenectomy combined with longitudinal pancreaticojejunostomy in the treatment of chronic pancreatitis: initial experience in 11 cases].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2024-01-01

回顾性队列研究纳入11例接受胰十二指肠切除术联合胰管纵行剖开吻合术(PD-L)的慢性胰腺炎合并胰头可疑恶性占位及胰体尾胰管结石患者,并与同期248例胰十二指肠切除术(PD)患者按1∶4倾向性评分匹配比较。PD-L组术中出血量、住院时间和术后住院时间均低于PD组,腹痛、腹胀、脂肪泻及糖尿病控制术后改善,但样本量小且为单中心设计,需进一步实践和长期随访。

要点

  • PD-L组术中出血量300(200)ml低于PD组500(500)ml(P<0.05)。
  • PD-L组住院时间21.0(7.0)d、术后住院时间13.0(8.0)d均低于PD组(P<0.05)。
  • PD-L组10例腹痛减轻、8例腹胀脂肪泻改善、5例糖尿病控制改善。

核心结论

  • PD-L可用于治疗慢性胰腺炎合并胰头可疑恶性占位及胰体尾多发胰管结石和狭窄,清除胰管结石较彻底,胰管引流通畅。
  • 具体效果仍需进一步实践和长期随访。

研究设计与样本

  • 本研究为回顾性队列研究,PD-L组为2021年12月至2023年9月西安交通大学第一附属医院肝胆外科收治的11例慢性胰腺炎合并胰头可疑恶性占位及胰体尾胰管结石患者,均为男性,年龄(49.0±11.2)岁(范围:32~70岁)。
  • PD组为同期收治的248例胰十二指肠切除术患者,男性157例、女性91例,年龄(61.5±10.8)岁(范围:27~82岁),病理学类型为胰腺癌或慢性胰腺炎87例。
  • 采用倾向性评分匹配法均衡两组混杂偏倚,卡钳值0.1,1∶4最近邻匹配法匹配;两组间比较采用独立样本t检验、Mann-Whitney U检验或χ2检验。

主要发现

  • PD-L组术中出血量[M(IQR)]300(200)ml低于PD组500(500)ml(P<0.05)。
  • PD-L组住院时间21.0(7.0)d、术后住院时间13.0(8.0)d均低于PD组25.0(8.5)d、17.0(5.0)d(P值均<0.05)。
  • 两组手术时间和术后并发症发生率的差异无统计学意义(P值均>0.05)。
  • PD-L组术后随访时间5(5)个月(范围:3~21个月),失访1例,其余10例腹痛均较术前减轻,8例腹胀、脂肪泻较术前改善,5例合并糖尿病者术后糖化血红蛋白、空腹血糖较术前改善。

关键数值与推荐

  • PD-L组术中出血量300(200)ml vs PD组500(500)ml(PD-L组较PD组降低,P<0.05)。
  • PD-L组住院时间21.0(7.0)d vs PD组25.0(8.5)d(PD-L组较PD组降低,P<0.05)。
  • PD-L组术后住院时间13.0(8.0)d vs PD组17.0(5.0)d(PD-L组较PD组降低,P<0.05)。
  • 两组手术时间和术后并发症发生率差异无统计学意义(P值均>0.05)。

临床怎么用

  • 作者认为PD-L可用于治疗慢性胰腺炎合并胰头可疑恶性占位及胰体尾多发胰管结石和狭窄,清除胰管结石较彻底,胰管引流通畅。
  • 作者指出具体效果仍需进一步实践和长期随访。

局限性

  • 本研究为单中心设计。
  • 本研究样本量小。
  • 具体效果仍需进一步实践和长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the surgical strategy for chronic pancreatitis complicated with suspected malignant lesions in the pancreatic head and pancreatolithiasis in the distal pancreas. Methods: This is a retrospective cohort study. Clinical data from 11 patients with chronic pancreatitis who underwent pancreaticoduodenectomy combined with longitudinal pancreaticojejunostomy(PD-L) were retrospectively collected(PD-L group) from the Department of Hepatobiliary Surgery of the First Affiliated Hospital of Xi'an Jiaotong University between December 2021 and September 2023. All patients were male with an age of (49.0±11.2) years(range:32 to 70 years). Their primary preoperative diagnoses included pancreatic lesions, chronic pancreatitis, pancreatolithiasis, and dilatation of the pancreatic duct. Data from 248 patients who underwent pancreaticoduodenectomy(PD) during the same period were retrospectively collected(PD group). There were 157 males and 91 females in the PD group, with an age of (61.5±10.8) years(range:27 to 82 years). Among them, 87 cases were diagnosed as pancreatic cancer or chronic pancreatitis. The propensity score matching method was used to reduce confounding bias between the two groups. The caliper value of 0.1 was used and the 1∶4 nearest neighbor matching method was used for the matching. Comparisons between the two groups were made using the independent sample t test, Mann-Whitney U test or χ2 test,respectively. Results: After complete excision of the specimen during pancreaticoduodenectomy, the key surgical step of PD-L was longitudinal pancreaticojejunostomy in the remaining pancreas. Intraoperative blood loss in the PD-L group was lower than that in the PD group [M(IQR)](300(200)ml vs. 500(500)ml, respectively; P<0.05). Similarly, hospitalization days(21.0(7.0)days vs. 25.0(8.5)days) and postoperative hospitalization days(13.0(8.0)days vs. 17.0(5.0) days) were also lower in the PD-L group compared to the PD group (P<0.05). There were no significant differences in the operation time and postoperative complication rate between the two groups(P>0.05). In the PD-L group, the postoperative follow-up time was 5(5)months(range: 3 to 21 months). One case was lost for follow-up. Abdominal pain was relieved in 10 patients. Additionally, abdominal distension and steatosis were alleviated in 8 cases. Furthermore, 5 cases of diabetes mellitus showed improved control of HbA1c and fasting blood glucose levels after surgery. Conclusions: PD-L treatment can be used to treat chronic pancreatitis complicated by suspected malignant lesions in the pancreatic head and pancreatolithiasis in the distal pancreas. PD-L also has advantages in removing stones from the pancreatic duct and evaporation of pancreatic fluid. However, due to the single-center design and the small sample size of this study, further practice and long-term follow-up are still necessary. 目的: 探讨慢性胰腺炎合并胰头可疑恶性占位及胰体尾胰管结石的手术治疗效果。 方法: 本研究为回顾性队列研究。回顾性收集2021年12月至2023年9月西安交通大学第一附属医院肝胆外科收治的接受胰管纵行剖开吻合的胰十二指肠切除术(PD-L)治疗的11例慢性胰腺炎合并胰头可疑恶性占位及胰体尾胰管结石患者的资料(PD-L组)。患者均为男性,年龄(49.0±11.2)岁(范围:32~70岁)。术前主要诊断均包括胰腺占位性病变、慢性胰腺炎、胰管结石、胰管扩张。回顾性收集该科同期收治的接受胰十二指肠切除术(PD)的248例患者资料(PD组);男性157例,女性91例;年龄(61.5±10.8)岁(范围:27~82岁);病理学类型为胰腺癌或慢性胰腺炎87例。采用倾向性评分匹配法均衡两组的混杂偏倚,卡钳值为0.1,采用1∶4最近邻匹配法进行匹配。两组间数据的比较采用独立样本t检验、Mann-Whitney U检验或χ2检验。 结果: PD-L组术中出血量[M(IQR)][300(200)ml]、住院时间[21.0(7.0)d]和术后住院时间[13.0(8.0)d]均低于PD组[500(500)ml、25.0(8.5)d、17.0(5.0)d](P值均<0.05)。两组其他围手术期资料的差异无统计学意义(P值均>0.05)。PD-L组术后随访时间为5(5)个月(范围:3~21个月),失访1例,其余10例腹痛均较术前减轻,8例腹胀、脂肪泻较术前改善,5例合并糖尿病者术后糖化血红蛋白、空腹血糖较术前改善。 结论: PD-L可用于治疗慢性胰腺炎合并胰头可疑恶性占位及胰体尾多发胰管结石和狭窄,清除胰管结石较彻底,胰管引流通畅,但具体效果仍需进一步实践和长期随访。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu S, Duan WX, Yang X, et al. [Pancreaticoduodenectomy combined with longitudinal pancreaticojejunostomy in the treatment of chronic pancreatitis: initial experience in 11 cases]. Zhonghua Wai Ke Za Zhi. 2024. PMID: 38548610. doi:10.3760/cma.j.cn112139-20231202-00251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。